Top 10 Reasons to Buy IMTL

Top 10 Reasons to Buy IMTL

1. With a history of 50% gains on the swing from low to high and the
potential for a multibagger, IMTL looks poised again for a move. Full
size chart: https://tinyurl.com/yyfd2sg6

2. Joins with MadHive to leverage blockchain and decentralized technologies

3. In talks with a major Blue Chip company about a key partnership
arrangement, and will disclose more details on this very soon

4. IPShare™ platform will be ready for market within 60 days

5. In talks with a number of internet influencers and celebrity
personalities

6. designing our own unique marketplace that will include more than 20
million images for free use, providing us with a massive archive of live
assets for tracking and monetization using our IPShare™ technology

7. Higbee Associates, a very successful Copyright Infringement Law firm
with a well-established reputation for expert processing of Copyright
Infringement collections, will now handle all of our collection and
litigation directly for all of our domestic clientele.

8. IPShare(tm) video:
https://www.youtube.com/watch?v=ABs8K2cohpU&feature=youtu.be

9. Huge demand for image copyright protection:
https://www.imageprotect.com/

10. Shares Outstanding 253M 3/1/19; Authorized 750M 3/1/19

EPIC SHORT SQUEEZE ALERT $IVST

 

 

Shareholder word cloud collage business concept background

Shareholder word cloud collage business concept background

Top 10 Reasons to Buy IVST

1. Channeling for almost 6 months in the $0.15-$0.30 range, IVST is
ready for another breakout. Full size chart: https://tinyurl.com/y9lbw7xr

2. Set to Add $30 Million in Annual Revenue with Pending Acquisition

3. Media Efforts Take Root Ahead of Biotechnology Developments

4. 20% ownership in Stem Vax. StemVax brain tumor vaccine has been
granted patent approval after a nine year filing process

5. First half 2018 revenue growth 55.8%

6. No convertible debts, no warrants or options outstanding

7. Current assets of $877,861; Cash balance of $561,062

8. Winslow Asset Management, the first institutional investor in
Innovest Global, filed showing that they remain a long shareholder

9. OCT Pink Current

10. Shares Outstanding Shares 109M 9/14/18. Float Shares 11.7M 8/16/18

10 REASONS TO BUY $dirv

95926E81-AE4A-4464-9732-7653DC3A2755

http://directview.com/

Symbol: OTC: DIRV

Top 10 Reasons to Buy DIRV

1. Channeling for almost 2 months in this range, DIRV is ready for
$0.012 breakout. Full size chart: https://tinyurl.com/yawqmfqx

2. Launches Initiative to Grow Market Share in School Security and
Surveillance Technologies

3. Files For Uplisting to be Traded on the OTCQB Venture Market; OTCQB
Certification filed

4. Retires over $262,000 in debt; Restructures corporate finance

5. Reports Strong Upswing in Requests and Orders for Video Surveillance
and Access Control Systems

6. Inks Deal With Emerging Top-Tier California CBD Processing Facility

7. Sees $500K Jump in Revenues to Bring YTD Sales to $6 Million

8. 2017 revenues reached $2.9M, up 531% from 2016

9. Wins New Orders Valued in Excess of Half a Million Dollars

10. OTC QB uplisting any day. Shares Outstanding Shares 154M 5/21/18.
Float Shares 133M 4/30/18

http://directview.com/


This email has been checked for viruses by Avast antivirus software.
https://www.avast.com/antivirus

10 reasons to buy $ivst

 

 

CA8EEB07-79F4-4132-ADDD-CB4B70BD72E9

Top 10 Reasons to Buy IVST

1. 3 days dancing around the 50MA resistance, ready to turn it into
support?  48C0AF3C-C2F8-40C6-99E3-3B5DB58D9A30

2. Call Center Contract Billings With Fortune 500 Company to Exceed $1
Million Over First Twelve Months

3. Wins $650,000 Contract with Fortune 500 Company

4. Rapidly Growing Commercial & Industrial Division Hits $4 Million
Revenue and Plans to Continue Triple Digit Growth

5. Signs High Five-Figure Sales Contract to Upgrade a 200,000 Sq. Ft.
Facility, Another LEEP Project

6. Record $326K Sales in April and Several Significant Accomplishments

7. Signs Two Energy Contracts Totaling 6 Figures, Announces Update On
Audit and Uplisting Plans

8. Signs $118K Sales Contract For First DCR Client, First of Several
Outstanding Proposals for the New Technology

9. $932K in Current Assets and Cancelled 50 Million Shares, Q1 Highlights

10. Shares Outstanding Shares 96.5M 3/31/18. Float Shares 11.7M 3/31/18

Innovest Global, Inc.
Symbol: OTC: IVST
Brought to you by www.bluehorseshoealerts.com

10 reasons to buy $dirv

FAAEEDAE-D58F-4177-87CC-29D2A980A245
Blue Horseshoe Alerts Presents:
DirectView Holdings, Inc.
Symbol: OTC: DIRV
Top 10 Reasons to Buy DIRV
1. Bounce ready after a small flush today. Holding the 50 ma. Full size chart: https://tinyurl.com/yawqmfqx
2. Chosen to Design and Implement Security and Surveillance Upgrade of High Profile Park Avenue Office Towers in New York City
3. Files For Uplisting to be Traded on the OTCQB Venture Market
4.  Virtual Surveillance Engaged by a S&P 500 US Commercial Airline Federal Credit Union Headquartered in the Southwest
5. Redesign Its Multi-Million Dollar Ecommerce Surveillance Website for a 2018 Summer Relaunch
6. Inks Deal With Emerging Top-Tier California CBD Processing Facility
7. Sees $500K Jump in Revenues to Bring YTD Sales to $6 Million
8. 2017 revenues reached $2.9M, up 531% from 2016
9. 2017 gross profit reached $1.3M, up 450% from 2016
10. OTC QB uplisting. Shares Outstanding Shares 141M 4/30/18. Float Shares 133M 4/30/18
268C10B5-653F-4FFD-BE3E-A7CACCF8DC61
Brought to you by: Blue Horseshoe Alerts
Sign up for our free newsletter

10 REASONS TO BUY $CPWR

D7EFCA63-EA33-4C4A-AE19-F5211EC71EE8Ocean Thermal Energy Corp.

http://otecorporation.com/

Symbol: OTC:CPWR

Top 10 Reasons to Buy CPWR

1. Support line at $0.17 held the past week. Could be reversal ready.
Full size chart: https://tinyurl.com/ybydb28l

2. Targets synergistic companies for acquisition. Due diligence in
process for 2 already.

3. Joined the Global Sustainable Tourism Council (GSTC)

4.  Project developer for Ocean Thermal Energy Conversion (OTEC) plants
that generate renewable energy without the use of fossil fuels

5. Explores deployment of OTEC renewable energy and water in the
philippines; conducts leetings with Filipino Leaders

6.  Net-zero carbon footprint EcoVillage in development

7. Col. Bob Griffin joins OTE as Chief Operations Officer

8. Seawater Air Conditioning (SWAC) technology produces air conditioning
without the use of chemical agents.

9. 7 large scale projects in the works: http://otecorporation.com/projects/

10. OTC QB. Shares Outstanding Shares 122M 3/20/18. Float Shares 21M 2/13/18

http://otecorporation.com/

Brought to you by: Blue Horseshoe Alerts
www.bluehorseshoealerts.com
Sign up for our news letter

10 reasons to buy $ngtf

IMG_0483

NightFood Holdings Inc.

http://nightfood.com/

Symbol: NGTF
Top 10 Reasons to Buy NGTF

1. After months of near 0 volume. Major interested has focused on $NGTF
with the OTC QB up-list. Full size chart:
http://www.profitspi.com/stock/view.aspx?v=stock-chart&uv=110794&p=ngtf

2. CEO interview on Fox Business 4/30/17

3. New flavors, new formats.

4. Secures $5m in funding

5. Looking at merger and acquisition options

6. The only nighttime craving health food

7. Engages leading e-commerce agency

8. Almost half of all snacking occurs between dinner and bed, resulting
in over $1B/week in consumer spending

9. Shares Outstanding 29,384,432 a/o Mar 30, 2017, Float 4,331,000 a/o
Mar 30, 2017

10. OTC QB Up-List Completed Today

huge upside DOCASA, Inc.

 

docasa-inc-logo-FINAL-BLACK

 

http://docasainc.com/

Symbol: DCSA

Why DOCASA?

 

 

DOCASA, Inc. invests in the rapidly growing specialty coffee market, principally in the United Kingdom (UK) which is currently a $10 Billion Dollar a year industry that is expected to grow to in excess of $20 Billion by 2025.

Starbucks capitalized on the explosive coffee market here in the USA. With an IPO at $17/sh in Jun 1992, Starbucks became the caffeine darling of the market.

Flash forward to 2017 and DOCASA. Are we witnessing the same idea in the UK?

As science continues to reaffirm that caffeinated coffee and tea is healthy for many people, the market continues to grow and demand outpaces supply. (foodrevolution.com)

An interview with the CEO, Ashley Lopez: https://theculturetrip.com/europe/united-kingdom/england/london/articles/get-your-caffeine-fix-with-partner-ceo-ashley-lopez/

Award winning, market leading Department of Coffee and Social Affairs, Ltd is DOCASA’s foray into the marketplace, starting in London with an eye to grow internationally.

Cold brew coffee has seen sensational growth and DOCASA has their own line: Bold Brew

Department of Coffee and Social Affairs is now open and available to over 1,400 staff and their visitors at the Canary Wharf and Soho office sites every working day of the year.

DOCASA, Inc. President & CEO, Ashley Lopez said, “We have identified a unique niche in providing workplace coffee shops in the offices of blue chip multi-national businesses and will continue to target such opportunities. To be able to open in Canary Wharf a third one of these workplace coffee shops is a validation both of our brand and of the demand for our quality coffee and food offerings within the working environment.  Sources within the organization tell us their staff’s daily interactions have increased significantly and that additional revenue are being generated.”

For the latest in news and filings: http://www.otcmarkets.com/stock/DCSA/profile

http://docasainc.com/

https://departmentofcoffee.com/

 

download (6)

 

 

BAR CHART GIVES $OBMP A STRONG BUY

$obmp

OncBioMune Pharmaceuticals, Inc.

http://oncbiomune.com/

Symbol: OBMP

Top 10 Reasons to Buy OBMP

1. Consolidation over the past week looks to be over, next move up on the charts starting. Full size chart

 

$obmp12

 

2. Lead product is ProscaVax that is in the planning stage of a Phase II clinical trial for the treatment of prostate cancer

3. A clinical stage biopharmaceutical company that develops cancer immunotherapy products

4. Announces Cancer Vaccine Poster Presentation at the 2017 American Association for Cancer Research Meeting

5. 9 of the 14 patients that have received 6 vaccines have had increased PSA doubling time, suggesting ProscaVax is slowing tumor growth.

6. Preparing to enter a Phase 2/3 trial in Mexico through a Joint Venture with its acquisition target and Mexican partner Vital Laboratorios S.A. de C.V

7. Departments of Urology and Oncology Approve Protocol for OncBioMune’s Phase 2/3 Trial of ProscaVax for Prostate Cancer in Mexico

8. Awarded Patent in Europe Protecting Novel Cancer Vaccine Technology

9. Shares Outstanding 61,158,013 a/o Feb 24, 2017; Float 11,861,349 a/o Feb 24,2017

10. OTC QB SEC Reporting Current

http://oncbiomune.com/

Brought to you by: Blue Horseshoe Alerts
www.bluehorseshoealerts.com
Sign up for our free newsletter

 

 

 

 

1 2